Study to Evaluate a Procedure for Intra-articular Injection of FX006 in Patients With Osteoarthritis of the Hip
Status:
Completed
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
This is a multi-center, single-arm, open-label study of FX006 in patients with hip OA. A
maximum number of approximately 30 patients may be enrolled in this protocol. All enrolled
patients will receive a single intra-articular (IA) injection of FX006.